{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:02Z","timestamp":1790716562836,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"science and technology project of Zhejiang medical and health department","award":["2017182371"],"award-info":[{"award-number":["2017182371"]}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2017A610175"],"award-info":[{"award-number":["2017A610175"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.neulet.2017.09.064","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T16:32:52Z","timestamp":1506961972000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Chronic trans-astaxanthin treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with chronic pain"],"prefix":"10.1016","volume":"662","author":[{"given":"Xi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfeng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianshu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.09.064_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","article-title":"Mechanisms of neuropathic pain","volume":"52","author":"Campbell","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2017.09.064_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neulet.2017.09.064_bib0015","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1172\/JCI61884","article-title":"Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression","volume":"122","author":"Kim","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2017.09.064_bib0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neulet.2017.09.064_bib0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2017.09.064_bib0030","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.3390\/md13095750","article-title":"Astaxanthin as a potential neuroprotective agent for neurological diseases","volume":"13","author":"Wu","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.neulet.2017.09.064_bib0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jsfa.7131","article-title":"The effect of astaxanthin on the aging rat brain:gender-related differences in modulating inflammation","volume":"96","author":"Balietti","year":"2016","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.neulet.2017.09.064_bib0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/molecules21030382","article-title":"Effects of astaxanthin from litopenaeus vannamei on carrageenan-Induced edema and pain behavior in mice","volume":"21","author":"Kuedo","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.neulet.2017.09.064_bib0045","doi-asserted-by":"crossref","first-page":"25552","DOI":"10.18632\/oncotarget.16069","article-title":"The antidepressant-like effect of trans-astaxanthin involves the serotonergic system","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neulet.2017.09.064_bib0050","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/PSY.0b013e318268de9f","article-title":"Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway","volume":"74","author":"Sublette","year":"2012","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neulet.2017.09.064_bib0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/1381612821666141121114917","article-title":"Serotonergic system and its role in epilepsy and neuropathic pain treatment: a review based on receptor ligands","volume":"21","author":"Panczyk","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neulet.2017.09.064_bib0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2016.08.029","article-title":"Trans-astaxanthin attenuates lipopolysaccharide-induced neuroinflammation and depressive-likebehavior in mice","volume":"1649","author":"Jiang","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2017.09.064_bib0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.11.003","article-title":"Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain","volume":"33","author":"Yalcin","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2017.09.064_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2017.09.064_bib0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2005.06.002","article-title":"The effects of curcumin on depressive-like behaviors in mice","volume":"518","author":"Xu","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2017.09.064_bib0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and models of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2017.09.064_bib0085","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressant","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neulet.2017.09.064_bib0090","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.1038\/srep09043","article-title":"Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic system","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2017.09.064_bib0095","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00726-013-1602-1","article-title":"Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease","volume":"45","author":"Fatokun","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.neulet.2017.09.064_bib0100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2017.09.064_bib0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0005-2736(01)00326-1","article-title":"Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin","volume":"1512","author":"Goto","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2017.09.064_bib0110","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1523\/JNEUROSCI.18-06-02239.1998","article-title":"Exposureto acute stress induces brain interleukin-1beta protein in the rat","volume":"18","author":"Nguyen","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.09.064_bib0115","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0166-2236(00)01661-1","article-title":"Interleukin 1 in the brain: biology, pathology andtherapeutic target","volume":"23","author":"Rothwell","year":"2000","journal-title":"Trends Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017308169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017308169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T15:58:38Z","timestamp":1603036718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017308169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":23,"alternative-id":["S0304394017308169"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.09.064","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic trans-astaxanthin treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with chronic pain","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.09.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}